Canagliflozin, dapagliflozin, and empagliflozin exerted antiplatelet activity

Author(s)

Lescano, Caroline Honaiser ; Portugal Torres, Pedro Henrique ; Antunes, Edson ; Monica, Fabiola Zakia

• Document type: Journal article
• Source: British Journal of Pharmacology; v. 177, n. 11, p. 3-pg., 2020-06-01.
• FAPESP's process: 18/21880-2 - Characterization of the periprostatic adipose tissue and its effect in the functional activity of the prostate from obese mice treated or not with mirabgron, a beta-3 adrenoceptor agonist.
• Grantee: Fabíola Taufic Monica Iglesias
• Support Opportunities: Regular Research Grants
• FAPESP's process: 17/15175-1 - Modulation of soluble guanylate cyclase and the intracellular levels of cyclic nucleotides in the lower urinary tract and prostate
• Grantee: Edson Antunes
• Support Opportunities: Research Projects - Thematic Grants
• FAPESP's process: 17/26687-3 - Pharmacological characterization of glyphlozins in isolated human platelets: in vitro, in vivo evaluation and molecular modeling
• Grantee: Caroline Honaiser Lescano
• Support Opportunities: Scholarships in Brazil - Post-Doctoral